Cancer Rehabilitation, A New Discipline Based upon Multidisciplinary Collaboration

Updata:01-01-1970

Source:
By:Shan Su

DOI: https://doi.org/10.30564/jams.v5i2.5231

Abstract:

Cancer Rehabilitation is a new discipline, a combination of tumor medication, immunology, psychology, nutritional science and exercise physiology etc.. The core of cancer rehabilitation is the therapy of natural immunology, which aims at activating T-cells, and restoring the bone marrow function impaired during chemo-radiation therapy. Cancer rehabilitation seeks to achieve the gradual recovery of the immune system, which in turn hinders recurrence and metastasis. In addition, with the help of psychological consultation, nutritional and physical exercise guidance, cancer patients may have a better chance at managing the risk of recurrence and metastasis, extending life expectancy with an improved quality of life. 

References:

[1] Chen, L., 2011. Research progress on the effect of chemotherapy on tumor immune function. Journal of Clinical Oncology. 16(9). [2] 2022.V1 version of NCCN Oncology Clinical Practice Guidelines: Small Cell Lung Cancer. [3] Verma, R., Foster, R.E., Horgan, K., et al., 2016. Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer. Breast Cancer Research. 18, 10. DOI: https://doi.org/10.1186/s13058-015-0669-x [4] Zhang, Sh.L., 2014. Nursing of Oral Ulcers Induced by Radiotherapy in Patients with Nasopharyngeal Carcinoma. World Latest Medical Information Digest. 14(1). [5] He, H., Zhu, J., Peng, N., et al., 2011. Investigation of gastrointestinal symptoms in cancer chemotherapy patients. Nursing Research. (025)004. [6] Tak, W., Mak Mary, E., 2010. Saunders Introduction to Immune Response. [7] Zheng, R., Zhang, S., Zeng, H. et al., 2022. Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center. 2(1). [8] Ren, K.L., 2019. Research progress of CAR-T immunotherapy. Article No.: 2096-43902019-0044-02. [9] Acoulay, E., Castro, P., Maamar, A., et al., 2021. Outcomes in Patients Treated with Chimeric Antigen Receptor T-cell Therapy who were Admitted to Intensive Care (CARTTAS): An International, Multicentre, Observational Cohort Study. The Lancet Haematology. 8(5). [10] Postow, M., Chesney, J., Pavlick, A., et al., 2015. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma. New England Journal of Medicine. 372, 2006-2017. DOI: https://doi.org/10.1056/NEJMoa1414428 [11] Wu, Y., Wang, S., 1995. Study on the Immune Function of Cordyceps Sinensis on Patients with Pulmonary Heart Disease (Bailing Capsule). Chinese Journal of Experimental Prescriptions. 1(1), 45. [12] Wang, Y.L., Zhou, H.P., 2000. The Influence of Taijiquan on Heart Rate. China Sports Science and Technology. 36(2).

Tags: